Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1887 1
1888 4
1894 1
1895 1
1896 1
1897 1
1901 2
1904 1
1907 1
1908 3
1909 1
1911 1
1912 4
1913 4
1914 1
1915 2
1916 1
1919 1
1920 2
1921 1
1922 1
1923 3
1924 2
1925 1
1927 1
1928 5
1929 3
1930 3
1931 3
1932 5
1934 2
1935 1
1936 7
1938 1
1945 6
1946 21
1947 41
1948 29
1949 17
1950 37
1951 41
1952 45
1953 47
1954 55
1955 50
1956 48
1957 49
1958 46
1959 72
1960 53
1961 46
1962 54
1963 85
1964 99
1965 77
1966 65
1967 109
1968 134
1969 119
1970 138
1971 137
1972 137
1973 140
1974 142
1975 116
1976 147
1977 134
1978 149
1979 165
1980 165
1981 188
1982 187
1983 232
1984 211
1985 251
1986 259
1987 252
1988 221
1989 241
1990 252
1991 260
1992 229
1993 213
1994 233
1995 203
1996 209
1997 183
1998 223
1999 224
2000 208
2001 170
2002 217
2003 196
2004 200
2005 215
2006 238
2007 248
2008 278
2009 275
2010 290
2011 295
2012 280
2013 261
2014 280
2015 295
2016 305
2017 283
2018 297
2019 314
2020 354
2021 378
2022 370
2023 342
2024 364
2025 313

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13,844 results

Results by year

Filters applied: . Clear all
Page 1
Raynaud's phenomenon.
Devgire V, Hughes M. Devgire V, et al. Br J Hosp Med (Lond). 2019 Nov 2;80(11):658-664. doi: 10.12968/hmed.2019.80.11.658. Br J Hosp Med (Lond). 2019. PMID: 31707892 Review.
Therefore, hospital-based specialists are frequently involved in the care of patients with Raynaud's phenomenon and need to be aware of associated conditions and prescribed medications for Raynaud's phenomenon. In particular, Raynaud's ph …
Therefore, hospital-based specialists are frequently involved in the care of patients with Raynaud's phenomenon and need to be …
Raynaud's phenomenon.
Herrick AL, Wigley FM. Herrick AL, et al. Best Pract Res Clin Rheumatol. 2020 Feb;34(1):101474. doi: 10.1016/j.berh.2019.101474. Epub 2020 Jan 29. Best Pract Res Clin Rheumatol. 2020. PMID: 32007400 Review.
Raynaud's phenomenon (RP) is common, affecting approximately 5% of the population, and is important to the rheumatologist because it is often the presenting symptom of connective tissue disease, especially of systemic sclerosis (SSc)-spectrum disorders. ...Ho …
Raynaud's phenomenon (RP) is common, affecting approximately 5% of the population, and is important to the rheumatologist beca …
Raynaud's phenomenon.
Haque A, Hughes M. Haque A, et al. Clin Med (Lond). 2020 Nov;20(6):580-587. doi: 10.7861/clinmed.2020-0754. Clin Med (Lond). 2020. PMID: 33199324 Free PMC article.
Raynaud's phenomenon (RP) is a common vasospastic condition which affects ~5% of the general population. The majority of individuals have primary RP; however, Raynaud's can also occur secondary to a broad range of underlying medical conditions and drug …
Raynaud's phenomenon (RP) is a common vasospastic condition which affects ~5% of the general population. The majority of indiv …
A Review of Raynaud's Disease.
Temprano KK. Temprano KK. Mo Med. 2016 Mar-Apr;113(2):123-6. Mo Med. 2016. PMID: 27311222 Free PMC article. Review.
Raynaud's phenomenon is a relatively common but often unrecognized clinical syndrome causing characteristic color changes in the digits as a result of vasospasm. ...Differentiating between primary and secondary Raynaud's is important as secondary Ra …
Raynaud's phenomenon is a relatively common but often unrecognized clinical syndrome causing characteristic color changes in t …
Raynaud's phenomenon-an update on diagnosis, classification and management.
Pauling JD, Hughes M, Pope JE. Pauling JD, et al. Clin Rheumatol. 2019 Dec;38(12):3317-3330. doi: 10.1007/s10067-019-04745-5. Epub 2019 Aug 16. Clin Rheumatol. 2019. PMID: 31420815 Review.
Raynaud's phenomenon (RP) is used to describe a symptom complex caused by digital vascular compromise. ...Raynaud's phenomenon causes significant disease-related morbidity in autoimmune rheumatic diseases such as systemic sclerosis....
Raynaud's phenomenon (RP) is used to describe a symptom complex caused by digital vascular compromise. ...Raynaud's …
Painful Raynaud's mimics.
Zahn C, Puga C, Malik A, Khanna D. Zahn C, et al. Best Pract Res Clin Rheumatol. 2024 Mar;38(1):101948. doi: 10.1016/j.berh.2024.101948. Epub 2024 May 3. Best Pract Res Clin Rheumatol. 2024. PMID: 38704280 Review.
Raynaud's syndrome is a common finding in many autoimmune conditions. Accurately diagnosing Raynaud's, and differentiating it from mimicking conditions, is imperative in rheumatologic diseases. Raynaud's syndrome and Raynaud's …
Raynaud's syndrome is a common finding in many autoimmune conditions. Accurately diagnosing Raynaud's, and diffe …
Raynaud's phenomenon and related vasospastic disorders.
Choi E, Henkin S. Choi E, et al. Vasc Med. 2021 Feb;26(1):56-70. doi: 10.1177/1358863X20983455. Vasc Med. 2021. PMID: 33566754 Review.
Still, it is under-diagnosed, under-treated, and often confused with other conditions. Primary Raynaud's phenomenon (i.e., Raynaud disease) must be distinguished from secondary Raynaud's phenomenon (i.e., Raynaud syndrome) as long- …
Still, it is under-diagnosed, under-treated, and often confused with other conditions. Primary Raynaud's phenomenon (i.e., …
ESVM guidelines - the diagnosis and management of Raynaud's phenomenon.
Belch J, Carlizza A, Carpentier PH, Constans J, Khan F, Wautrecht JC, Visona A, Heiss C, Brodeman M, Pécsvárady Z, Roztocil K, Colgan MP, Vasic D, Gottsäter A, Amann-Vesti B, Chraim A, Poredoš P, Olinic DM, Madaric J, Nikol S, Herrick AL, Sprynger M, Klein-Weigel P, Hafner F, Staub D, Zeman Z. Belch J, et al. Vasa. 2017 Oct;46(6):413-423. doi: 10.1024/0301-1526/a000661. Epub 2017 Sep 12. Vasa. 2017. PMID: 28895508 Free article. Review.
Regarding the clinical diagnosis of Raynaud's phenomenon and its associated conditions, investigations and treatment are substantial, and yet no international consensus has been published regarding the medical management of patients presenting with this condition. M …
Regarding the clinical diagnosis of Raynaud's phenomenon and its associated conditions, investigations and treatment are subst …
[Raynaud's syndrome, 2024].
Fábián B, Csiki Z. Fábián B, et al. Orv Hetil. 2024 Apr 28;165(17):643-651. doi: 10.1556/650.2024.33026. Print 2024 Apr 28. Orv Hetil. 2024. PMID: 38678551 Review. Hungarian.
In this article, we review the latest findings of Raynaud's syndrome from the last 13 years after our previous paper published in 2011. We describe the main characteristics, the available diagnostic and therapeutic options of Raynaud's syndrome. ...We …
In this article, we review the latest findings of Raynaud's syndrome from the last 13 years after our previous paper published …
Raynaud's phenomenon.
Gayraud M. Gayraud M. Joint Bone Spine. 2007 Jan;74(1):e1-8. doi: 10.1016/j.jbspin.2006.07.002. Epub 2006 Dec 4. Joint Bone Spine. 2007. PMID: 17218139 Review.
They are associated with connective tissue disease; for example, 90% of patients with scleroderma experience Raynaud's phenomenon. ...The diagnosis of Raynaud's phenomenon rests on clinical grounds. Nailfold capillaroscopy and immunological test …
They are associated with connective tissue disease; for example, 90% of patients with scleroderma experience Raynaud's …
13,844 results
You have reached the last available page of results. Please see the User Guide for more information.